The Munich Lung Transplant Group: Intraoperative Extracorporeal Circulation in Lung Transplantation

Thoracic and Cardiovascular Surgeon

Volumn 63, Issue 8, 2015, Pages 706-714

  Hoechter, Dominik J ^a   Von Dossow, Vera ^a   Winter, Hauke ^b   Müller, Hans Helge ^c   Meiser, Bruno ^b   Neurohr, Claus ^b   Behr, Juergen ^b   Guenther, Sabina ^b   Hagl, Christian ^b   Schramm, René ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

anticoagulation; cardiopulmonary bypass; ECMO; extracorporeal circulation; lung transplantation

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRINOGEN; PROTHROMBIN COMPLEX; TRANEXAMIC ACID; ANTICOAGULANT AGENT; COAGULATING AGENT; HEPARIN;

ADULT; ANTICOAGULATION; ARTICLE; ASSISTED CIRCULATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; FEMALE; GRAFT RECIPIENT; HEPARINIZATION; HUMAN; LENGTH OF STAY; LUNG TRANSPLANTATION; LUNG VENTILATION; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; THROMBOCYTE TRANSFUSION; TRANSFUSION; VENTILATOR; ADVERSE EFFECTS; ARTIFICIAL VENTILATION; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COMPARATIVE STUDY; GERMANY; INTENSIVE CARE UNIT; LUNG; LUNG DISEASES; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; COAGULANTS; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; GERMANY; HEPARIN; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LUNG; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84949087937     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0035-1556873     Document Type: Article

References (17)

1. Cooper J. D., Patterson G. A., Trulock E. P.; Washington University Lung Transplant Group. Results of single and bilateral lung transplantation in 131 consecutive recipients. J Thorac Cardiovasc Surg: 1994; 107 2 460 470, discussion 470-471
2. Neurohr C., Huppmann P., Zimmermann G., et al. Munich Lung Transplant Group. Tacrolimus and mycophenolate mofetil as first line immunosuppression after lung transplantation. Transpl Int: 2009; 22 6 635 643
3. Ius F., Kuehn C., Tudorache I., et al. Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. J Thorac Cardiovasc Surg: 2012; 144 6 1510 1516
4. Diso D., Venuta F., Anile M., et al. Extracorporeal circulatory support for lung transplantation: institutional experience. Transplant Proc: 2010; 42 4 1281 1282
5. Triantafillou A. N., Pasque M. K., Huddleston C. B., et al. Predictors, frequency, and indications for cardiopulmonary bypass during lung transplantation in adults. Ann Thorac Surg: 1994; 57 5 1248 1251
6. Nagendran M., Maruthappu M., Sugand K. Should double lung transplant be performed with or without cardiopulmonary bypass? Interact Cardiovasc Thorac Surg: 2011; 12 5 799 804
7. Szeto W. Y., Kreisel D., Karakousis G. C., et al. Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome. J Thorac Cardiovasc Surg: 2002; 124 2 241 249
8. Asimakopoulos G., Smith P. L., Ratnatunga C. P., Taylor K. M. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg: 1999; 68 3 1107 1115
9. McRae K. Con: lung transplantation should not be routinely performed with cardiopulmonary bypass. J Cardiothorac Vasc Anesth: 2000; 14 6 746 750
10. Aigner C., Wisser W., Taghavi S., et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardiothorac Surg: 2007; 31 3 468 473, discussion 473-474
11. Machuca T. N., Collaud S., Mercier O., et al. Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg: 2015; 149 4 1152 1157
12. Cypel M., Keshavjee S. Extracorporeal life support as a bridge to lung transplantation. Clin Chest Med: 2011; 32 2 245 251
13. Fuehner T., Kuehn C., Hadem J., et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med: 2012; 185 7 763 768
14. Fischer S., Bohn D., Rycus P., et al. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the Extracorporeal Life Support Organization (ELSO) registry. J Heart Lung Transplant: 2007; 26 5 472 477
15. Bittner H. B., Binner C., Lehmann S., Kuntze T., Rastan A., Mohr F. W. Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Eur J Cardiothorac Surg: 2007; 31 3 462 467, discussion 467
16. Diamond J. M., Lee J. C., Kawut S. M., et al. Lung Transplant Outcomes Group. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med: 2013; 187 5 527 534
17. Bittner H. B., Lehmann S., Rastan A., et al. Outcome of extracorporeal membrane oxygenation as a bridge to lung transplantation and graft recovery. Ann Thorac Surg: 2012; 94 3 942 949, author reply 949-950